Redhill Biopharma Ltd RDHL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/24/24 EDT
0.46quote price arrow down-0.0078 (-1.6854%)
Volume
683
Close
0.4628quote price arrow up+0.0078 (+1.7143%)
Volume
101,438
52 week range
0.26 - 3.28
Loading...
  • Open0.46
  • Day High0.4698
  • Day Low0.455
  • Prev Close0.455
  • 52 Week High3.28
  • 52 Week High Date11/29/23
  • 52 Week Low0.26
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap14.748M
  • Shares Out31.87M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta3.56
  • YTD % Change-68.3

KEY STATS

  • Open0.46
  • Day High0.4698
  • Day Low0.455
  • Prev Close0.455
  • 52 Week High3.28
  • 52 Week High Date11/29/23
  • 52 Week Low0.26
  • 52 Week Low Date10/13/23
  • Market Cap14.748M
  • Shares Out31.87M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta3.56
  • YTD % Change-68.3

RATIOS/PROFITABILITY

  • EPS (TTM)3.69
  • P/E (TTM)0.13
  • Fwd P/E (NTM)-15.43
  • EBITDA (TTM)14.622M
  • ROE (TTM)-385.03%
  • Revenue (TTM)6.53M
  • Gross Margin (TTM)47.03%
  • Net Margin (TTM)366.25%
  • Debt To Equity (MRQ)56.69%

EVENTS

  • Earnings Date06/23/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Redhill Biopharma Ltd

 

Content From Our Affiliates

Profile

MORE
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640)...
Dror Ben-Asher
Chairman of the Board, Chief Executive Officer
Gilead Raday
Chief Operating Officer
Razi Ingber
Chief Financial Officer
Address
21 Ha'arba'a St.
Tel Aviv-yafo
6473921
Israel

Top Peers

SYMBOLLASTCHG%CHG
HLTH
Cue Health Inc
0.0925-0.0018-1.9088%
DTIL
Precision BioSciences Inc
12.74-0.26-2.00%
PSNL
Personalis Inc
1.34-0.10-6.94%
PLX
Protalix Biotherapeutics Inc
1.23+0.05+4.24%
FBIO
Fortress Biotech Inc
1.87+0.03+1.63%